Neuroendocrine tumors (NETs) are rare tumors that originate from neuroendocrine cells and commonly arise from the gastrointestinal and pulmonary system, with increasing incidence over the past decades [1]. While the course of NETs is generally indolent, high-grade neuroendocrine carcinomas can be aggressive with poor outcomes, and NETs can present with debilitating symptoms, including diarrhea, fatigue and flushing [2]. Vague symptomatology of NETs often leads to late diagnoses with many patient…